Cited by 1,163Lipoproteins and Cardiovascular HealthCholesterol and Lipid MetabolismParaoxonase enzyme and polymorphisms

The DOI matches its Crossref record; 56 of the 56 references it cites were found in a registry or an index.

A prospective study of cholesterol, apolipoproteins, and the risk of myocardial infarction.

Open access

Stampfer, Meir J., Sacks, Frank M., Salvini, Simonetta, Willett, Walter C., Hennekens, Charles H.·1991·New England Journal of Medicine

DOI 10.1056/nejm199108083250601

Open this paper in CoChat — free account Open PDF

Abstract

BACKGROUND: The independent contributions of subfractions of high-density lipoprotein (HDL) cholesterol (HDL2 and HDL3) and apolipoproteins in predicting the risk of myocardial infarction are unclear. Prospective data are sparse, but HDL2 is widely believed to be a more important predictor than HDL3. METHODS: Blood samples were collected at base line from 14,916 men (ages, 40 to 84 years) who were participants in the Physicians' Health Study. After five years of follow-up, plasma samples from 246 men with new myocardial infarction (case subjects) were analyzed together with specimens from 246 men matched to them for age and smoking status who had not had a myocardial infarction. RESULTS: The levels of total cholesterol and apolipoprotein B-100 were significantly associated with an increased risk of myocardial infarction (data on levels of low-density lipoprotein cholesterol were unavailable). Both HDL cholesterol and HDL2 levels were associated with a substantially decreased risk of myocardial infarction, but the HDL3 level was the strongest predictor; the relative risk was 0.3 (95 percent confidence interval, 0.2 to 0.6) for those in the fifth of the group with the highest HDL3 levels, as compared with the fifth with the lowest levels. The benefit of a higher HDL cholesterol level was most pronounced among those with lower total cholesterol levels. Levels of apolipoprotein A-I and apolipoprotein A-II were also associated with decreased risk. However, the levels of HDL subfractions and apolipoproteins did not add significantly to the value of a multivariate model that included the ratio of total to HDL cholesterol in predicting myocardial infarction, whereas that ratio remained a significant independent predictor of risk. After adjustment for other risk factors, a change of one unit in the ratio of total to HDL cholesterol was associated with a 53 percent change in risk (95 percent confidence interval, 26 percent to 85 percent). CONCLUSIONS: This study underscores the importance of HDL cholesterol in predicting the risk of myocardial infarction and demonstrates protective effects of both the HDL3 and HDL2 subfractions of HDL cholesterol. We found little or no predictive value for the levels of apolipoproteins A-I, A-II, and B or HDL subfractions after conventional risk factors and the ratio of total to HDL cholesterol were considered.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1056/nejm199108083250601

Cites

56 of 56 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

From the New York Times Magazine
Minsky, & Hyman, P. (1979) · Cited by 6,899
High-density lipoprotein cholesterol and cardiovascular disease. Four prospective American studies.
Gordon, D. J., Probstfield, J. L., Garrison, R. J., Neaton, J. D., Castelli, W. P., Knoke, J. D., Jacobs, D. R., Bangdiwala, S., & Tyroler, H. A. (1989) · Circulation · doi:10.1161/01.cir.79.1.8 · Cited by 3,162
Incidence of Coronary Heart Disease and Lipoprotein Cholesterol Levels
Castelli, W. P. (1986) · JAMA · doi:10.1001/jama.256.20.2835 · Cited by 2,512
Final Report on the Aspirin Component of the Ongoing Physicians' Health Study
Steering Committee of the Physicians' Health Study Research Group (1989) · New England Journal of Medicine · doi:10.1056/nejm198907203210301 · Cited by 2,267
THE TROMSØHEART-STUDY
Miller, N. E., Thelle, D. S., Førde, O. H., & Mjøs, O. D. (1977) · The Lancet · doi:10.1016/s0140-6736(77)92274-7 · Cited by 1,206
Separation and quantitation of subclasses of human plasma high density lipoproteins by a simple precipitation procedure
Gidez, L. I., Miller, G. J., Burstein, M., Slagle, S., & Eder, H. (1982) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)38059-7 · Cited by 757
Ischemic Heart Disease, Atherosclerosis, and Longevity
Gofman, J. W., Young, W., & Tandy, R. K. (1966) · Circulation · doi:10.1161/01.cir.34.4.679 · Cited by 587
Apolipoprotein A-I as a Marker of Angiographically Assessed Coronary-Artery Disease
Maciejko, J. J., Holmes, D. R., Kottke, B. A., Zinsmeister, A. R., Dinh, D. M., & Mao, S. J. T. (1983) · New England Journal of Medicine · doi:10.1056/nejm198308183090701 · Cited by 537
Report of the National Cholesterol Education Program Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. The Expert Panel
Goodman, D. S., Hulley, S. B., Clark, L. T., Davis, C. E., Fuster, V., LaRosa, J. C., Oberman, A., Schaefer, E. J., Steinberg, D., Brown, W. V., et al. (1988) · Archives of Internal Medicine · doi:10.1001/archinte.148.1.36 · Cited by 529
ARE APOLIPOPROTEINS BETTER DISCRIMINATORS THAN LIPIDS FOR ATHEROSCLEROSIS?
Avogaro, P., Bon, G. B., Avogaro, P., Cazzolato, G., & Quinci, G. B. (1979) · The Lancet · doi:10.1016/s0140-6736(79)91375-8 · Cited by 523

Show all 56 references

Research works printed but not linked: 10

Enger, 1979, Artery, 5, 170
Bennett, 1988, New York Times Magazine, 55
Jones PH, Gotto AM Jr. Assessment of lipid abnormalities. In: Hurst JW, Schlant RC, Rachley CE, Sonnenblick EH, Wenger NK, eds. The heart: arteries and veins. 7th ed. New York: McGraw-Hill, 1990:378–84.
10.1001/archinte.150.8.1645 · DOI
Musliner, 1988, Clin Chem, 34, B78
Hennekens, 1987, Circulation, 76, IV-501
Kempen, 1987, J Lab Clin Med, 109, 19
Avogaro P, Cazzolato G, Bittolo Bon G, Rorai E, Pontoglio E. Lipoprotein derangements in human atherosclerosis. In: Noseda G, Fragiacomo C, Fumagalli R, Paoletti R, eds. Lipoproteins and coronary atherosclerosis. Amsterdam: Elsevier, 1982:123–42.
Kladetzky, 1980, Artery, 7, 191
Desager JP, Rousseau M, Riesen WF, Harvengt C. Limitations of the predictive value for coronary vascular disease of plasma lipids and apoproteins AI, AII, B levels as measured before coronarography in 317 patients. In: de Gennes JL, Polonovski J, Paoletti R, eds. Latent dyslipoproteinemias and atherosclerosis. New York: Raven Press, 1984:165–74.

Sorted by citations

Items 601–700 of 999

Benefits and Difficulties in Measuring HDL Subfractions and Human Paraoxonase-1 Activity During Statin Treatment
Harangi, M., Seres, I., Harangi, J., & Paragh, G. (2009) · Cardiovascular Drugs and Therapy · doi:10.1007/s10557-009-6205-4 · Cited by 22
Consuming a diet complying with front-of-pack label criteria may reduce cholesterol levels: a modeling study
Vyth, E. L., Hendriksen, M. A. H., Roodenburg, A. J. C., Steenhuis, I. H., Raaij, J. M. A. V., Verhagen, H., Brug, J., & Seidell, J. C. (2011) · European Journal of Clinical Nutrition · doi:10.1038/ejcn.2011.193 · Cited by 24
Lipid abnormalities in the metabolic syndrome
Brinton, E. A. (2003) · Current Diabetes Reports · doi:10.1007/s11892-003-0056-3 · Cited by 22
Health problems associated with saturated and trans fatty acids intake
Zock, P. L. (2006) · Elsevier eBooks · doi:10.1533/9781845691073.1.3 · Cited by 23
Effect of treatment with human apolipoprotein A-I on atherosclerosis in uremic apolipoprotein-E deficient mice
Pedersen, T. X., Bro, S., Andersen, M. H., Etzerodt, M., Jauhiainen, M., Moestrup, S., & Nielsen, L. B. (2009) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2008.04.041 · Cited by 22
Why cholesterol as a central theme in coronary artery disease?
Sacks, F. M. (1998) · American Journal of Cardiology · doi:10.1016/s0002-9149(98)00717-6 · Cited by 18
Self-citation
Cardiovascular prognosis in relation to apolipoproteins and other lipid parameters in patients with stable angina pectoris treated with verapamil or metoprolol
Held, C., Hjemdahl, P., Rehnqvist, N., Björkander, I., Forslund, L., Brodin, U., Berglund, L., & Angelin, B. (1997) · Atherosclerosis · doi:10.1016/s0021-9150(97)00147-0 · Cited by 22
Fenofibrate improves postprandial chylomicron clearance in II B hyperlipoproteinemia
F�ger, B., Drexel, H., Hopferwieser, T., Miesenb�ck, G., Ritsch, A., Lechleitner, M., Tr�binger, G., & Patsch, J. R. (1994) · Journal of Molecular Medicine · doi:10.1007/bf00180044 · Cited by 22
Update on perioperative evaluation and management of cardiac disease in vascular surgery patients
Krupski, W. C. (2002) · Journal of Vascular Surgery · doi:10.1067/mva.2002.129647 · Cited by 22
Distribution of Lipid Phenotypes in Community-Living Men With Coronary Heart Disease
Bloomfield, H. E. (1992) · Archives of Internal Medicine · doi:10.1001/archinte.1992.00400240036005 · Cited by 22
Regulation of human apolipoprotein A-I expression in Caco-2 and HepG2 cells by all-trans and 9-cis retinoic acids.
Giller, T., Hennes, U., & Kempen, H. J. M. (1995) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)39859-x · Cited by 22
Fractional esterification rate of cholesterol in high density lipoprotein is correlated with low density lipoprotein particle size in children.
Ohta, T., Kakiuti, Y., Kurahara, K., Saku, K., Nagata, N., & Matsuda, I. (1997) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)37283-7 · Cited by 22
Beyond traditional metrics: evaluating the triglyceride-total cholesterol-body weight index (TCBI) in cardiovascular risk assessment
Rezaee, M., Kamrani, F., Imannezhad, M., Shahri, H. H., Saihood, W. K., Rezvani, A., Far, P. M., Mahaki, H., Esmaily, H., Moohebati, M., et al. (2025) · BMC Cardiovascular Disorders · doi:10.1186/s12872-025-04500-6 · Cited by 21
Influence of ATP-Binding Cassette Transporter 1 R219K and M883I Polymorphisms on Development of Atherosclerosis: A Meta-Analysis of 58 Studies
Yin, Y.-W., Li, J.-C., Gao, D., Chen, Y., Li, B., Wang, J., Liu, Y., Liao, S.-Q., Zhang, M.-J., Gao, C., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0086480 · Cited by 21
Inflammatory status modulates plasma lipid and inflammatory marker responses to kiwifruit consumption in hypercholesterolaemic men
Gammon, C. S., Kruger, R., Conlon, C. A., von Hurst, P. R., Jones, B., & Stonehouse, W. (2013) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2013.06.001 · Cited by 21
The Impact of Cigarette Smoking on Lipid Profile among Iraqi Smokers
Rashan, M. A., Dawood, O. T., AbdulRazzaq, H. A., & Hassali, M. A. (2016) · International journal of collaborative research on internal medicine & public health · Cited by 21
Immunochemical detection of circulating oxidized high-density lipoprotein with antioxidized apolipoprotein A-I monoclonal antibody
Nakano, T., & Nagata, A. (2003) · Journal of Laboratory and Clinical Medicine · doi:10.1016/s0022-2143(03)00026-x · Cited by 21
Fifty-three year follow-up of coronary heart disease versus HDL2 and other lipoproteins in Gofman's Livermore Cohort
Williams, P. T. (2011) · Journal of Lipid Research · doi:10.1194/jlr.m019356 · Cited by 21
Plasma high-density lipoprotein cholesterol but not apolipoprotein A-I is a good correlate of the visceral obesity—insulin resistance dyslipidemic syndrome
Couillard, C., Lamarche, B., Tchernof, A., Prud’homme, D., Tremblay, A., Bouchard, C., Moorjanit, S., Nadeau, A., Lupien, P. J., & Després, J. (1996) · Metabolism · doi:10.1016/s0026-0495(96)90164-x · Cited by 22
Essential Fatty Acid and Prostaglandin Metabolism in Sjögren’s Syndrome, Systemic Sclerosis and Rheumatoid Arthritis
Horrobin, D. F. (1986) · Scandinavian Journal of Rheumatology · doi:10.1080/15027732.1986.12461420 · Cited by 21
Effects of Phenytoin on Plasma High‐Density Lipoprotein Cholesterol Levels in Men with Low Levels of High‐Density Lipoprotein Cholesterol
Goerdt, C. J., Keith, M., & Bloomfield, H. E. (1995) · The Journal of Clinical Pharmacology · doi:10.1002/j.1552-4604.1995.tb04118.x · Cited by 21
Familial lipoprotein disorders and premature coronary artery disease
Schaefer, E. J. (1994) · Medical Clinics of North America · doi:10.1016/s0025-7125(16)30175-4 · Cited by 21
Protein-DNA Interactions at a Drug-responsive Element of the Human Apolipoprotein A-I Gene
Zhang, X., Chen, Z.-Q., Wang, Z., Mohan, W. S., & Tam, S. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.43.27152 · Cited by 21
Phosphoproteins Regulated by the Interaction of High-Density Lipoprotein With Human Skin Fibroblasts
Garver, W. S., Deeg, M. A., Bowen, R. F., Culala, M. M., Bierman, E. L., & Oram, J. F. (1997) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.17.11.2698 · Cited by 21
A cross-sectional study of endogenous tissue plasminogen activator, total cholesterol, HDL cholesterol, and apolipoproteins A-I, A-II, and B-100.
Ridker, P. M., Vaughan, D. E., Stampfer, M. J., Sacks, F. M., & Hennekens, C. H. (1993) · Arteriosclerosis and Thrombosis A Journal of Vascular Biology · doi:10.1161/01.atv.13.11.1587 · Cited by 21
Self-citation
Simvastatin
Chrisp, P., Lewis, N. J. W., & Milne, R. J. (1992) · PharmacoEconomics · doi:10.2165/00019053-199201020-00009 · Cited by 20
Association of CETP and LIPC Gene Polymorphisms with HDL and LDL Sub-fraction Levels in a Group of Indian Subjects: A Cross-Sectional Study
Todur, S. P., & Ashavaid, T. F. (2012) · Indian Journal of Clinical Biochemistry · doi:10.1007/s12291-012-0259-y · Cited by 20
Traditional Dietary Pattern Is Associated with Elevated Cholesterol among the Inuit of Nunavik
Labonté, M., Dewailly, É., Lucas, M., Château‐Degat, M., Couture, P., & Lamarche, B. (2014) · Journal of the Academy of Nutrition and Dietetics · doi:10.1016/j.jand.2013.12.017 · Cited by 20
Linolelaidic acid induces apoptosis, cell cycle arrest and inflammation stronger than elaidic acid in human umbilical vein endothelial cells through lipid rafts
Li, J., Rao, H., Bin, Q., Fan, Y., Li, H., & Deng, Z. (2016) · European Journal of Lipid Science and Technology · doi:10.1002/ejlt.201600374 · Cited by 20
Serum Apo A-1 and Its Role as a Biomarker of Coronary Artery Disease
Rahim, S., Abdullah, H. M. A., Ali, Y., Khan, U. I., Ullah, W., Shahzad, M. A., & Waleed, M. (2016) · Cureus · doi:10.7759/cureus.941 · Cited by 20
Association between high-density lipoprotein subfractions and low-grade inflammation, insulin resistance, and metabolic syndrome components: The ELSA-Brasil study
Generoso, G., Benseñor, I. M., Santos, R. D., Santos, I. S., Goulart, A. C., Jones, S. R., Kulkarni, K. R., Blaha, M. J., Toth, P. P., Lotufo, P. A., et al. (2018) · Journal of clinical lipidology · doi:10.1016/j.jacl.2018.05.003 · Cited by 20
Serum lipoprotein cholesterol and triglyceride concentrations in pigs fed diets containing fish oil, milkfat, olive oil and coconut oil
Allan, F. J., Thompson, K. G., James, K. A. C., Manktelow, B. W., Koolaard, J. P., Johnson, R. N., & McNutt, P. V. (2001) · Nutrition Research · doi:10.1016/s0271-5317(01)00267-6 · Cited by 20
Subfractions of High-Density Lipoprotein-Cholesterol and Carotid Intima-Media Thickness
Tiozzo, E., Gardener, H. E., Hudson, B. I., Dong, C., Della‐Morte, D., Crisby, M., Goldberg, R. B., Elkind, M. S. V., Cheung, Y. K., Wright, C. B., et al. (2016) · Stroke · doi:10.1161/strokeaha.115.012009 · Cited by 20
Association of two apolipoprotein A‐I gene MspI polymorphisms with high density lipoprotein (HDL)‐cholesterol levels and indices of obesity in selected healthy Chinese subjects and in patients with early‐onset type 2 diabetes
Ma, Y. Q., Thomas, G. N., Ng, M. C. Y., Critchley, J., Cockram, C. S., Chan, J. C. N., & Tomlinson, B. (2003) · Clinical Endocrinology · doi:10.1046/j.1365-2265.2003.01865.x · Cited by 20
Double-blind, randomized study comparing the effects of two monophasic oral contraceptives containing ethinylestradiol (20 μg or 30 μg) and levonorgestrel (100 μg or 150 μg) on lipoprotein metabolism
Scharnagl, H., Petersen, G., Nauck, M. A., Teichmann, A. T., Wieland, H., & März, W. (2004) · Contraception · doi:10.1016/j.contraception.2003.10.004 · Cited by 20
Association of two apolipoprotein A-I gene MspI polymorphisms with lipid and blood pressure levels
Ma, Y. Q., Thomas, G. N., & Tomlinson, B. (2005) · International Journal of Cardiology · doi:10.1016/j.ijcard.2004.10.017 · Cited by 20
A prospective study of the APOA1 XmnI and APOC3 SstI polymorphisms in the APOA1/C3/A4 gene cluster and risk of incident myocardial infarction in men
Liu, S., Song, Y., Hu, F. B., Niu, T., Ma, J., Gaziano, J. M., & Stampfer, M. J. (2004) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2004.07.002 · Cited by 20
Self-citation
Transforming growth factor beta is sequestered into an inactive pool by lipoproteins
Grainger, D. J., Byrne, C. D., Witchell, C., & Metcalfe, J. C. (1997) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)34948-8 · Cited by 20
Design Considerations in Molecular Epidemiology
Schulte, P. A., Rothman, N., & Schottenfeld, D. (1993) · Elsevier eBooks · doi:10.1016/b978-0-08-092566-0.50010-0 · Cited by 20
Multicentre criterion based audit of the management of induced abortion in Scotland
Penney, G., Glasier, A. F., & Templeton, A. (1994) · BMJ · doi:10.1136/bmj.309.6946.15 · Cited by 20
New and Emerging Biomarkers in Cardiovascular Disease
Cahill, L. E., Bertoia, M. L., Aroner, S. A., Mukamal, K. J., & Jensen, M. K. (2015) · Current Diabetes Reports · doi:10.1007/s11892-015-0661-y · Cited by 20
Effects of products made from a high-palmitic acid, trans-free semiliquid fat or a high-oleic acid, low-trans semiliquid fat on the serum lipoprotein profile and on C-reactive protein concentrations in humans
Mensink, R. P. (2007) · European Journal of Clinical Nutrition · doi:10.1038/sj.ejcn.1602756 · Cited by 19
Association of High‐Density Lipoprotein‐Cholesterol Versus Apolipoprotein A‐I With Risk of Coronary Heart Disease: The European Prospective Investigation Into Cancer‐Norfolk Prospective Population Study, the Atherosclerosis Risk in Communities Study, and the Women's Health Study
van Capelleveen, J. C., Bochem, A. E., Boekholdt, S. M., Mora, S., Hoogeveen, R. C., Ballantyne, C. M., Ridker, P. M., Sun, W., Barter, P. J., Tall, A. R., et al. (2017) · Journal of the American Heart Association · doi:10.1161/jaha.117.006636 · Cited by 21
Lipid abnormalities in Greek patients with coronary artery disease
Elisaf, M., Siamopoulos, K. C., Tselegarides, T. J., Bairaktari, E. T., Goudevenos, J. A., Tselepis, A. D., Tsolas, O., & Sideris, D. A. (1997) · International Journal of Cardiology · doi:10.1016/s0167-5273(96)02916-6 · Cited by 19
Lipoprotein (a), Lipids, Aspirin, and Risk of Myocardial Infarction in the Physician's Health Study
Ariyo, A., Hennekens, C. H., Stampfer, M. J., & Ridker, P. M. (1998) · European Journal of Cardiovascular Prevention & Rehabilitation · doi:10.1177/174182679800500410 · Cited by 19
Self-citation
Premenopause contraception with monthly injectable Mesigyna® with special emphasis on serum lipid and bone density patterns
Kesserü, E., Etchepareborda, J. J., Wikinski, R. L. W., & Beier, S. (2000) · Contraception · doi:10.1016/s0010-7824(00)00110-4 · Cited by 19
Apolipoprotein Modulation of Streptococcal Serum Opacity Factor Activity against Human Plasma High-Density Lipoproteins
Rosales, C., Gillard, B. K., Courtney, H. S., Blanco‐Vaca, F., & Pownall, H. J. (2009) · Biochemistry · doi:10.1021/bi901087z · Cited by 18
Nutritional Management of Type 2 Diabetes Mellitus and Obesity and Pharmacologic Therapies to Facilitate Weight Loss
Vetter, M. L., Amaro, A., & Volger, S. (2014) · Postgraduate Medicine · doi:10.3810/pgm.2014.01.2734 · Cited by 22
Plasma Levels of Preβ1-HDL Are Significantly Elevated in Non-Dialyzed Patients with Advanced Stages of Chronic Kidney Disease
Kuchta, A., Ćwiklińska, A., Czaplińska, M., Wieczorek, E., Kortas‐Stempak, B., Gliwińska, A., Dąbkowski, K., Sałaga-Zaleska, K., Mickiewicz, A., Dębska-Ślizień, A. M., et al. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20051202 · Cited by 18
Dyslipidemia and Cardiovascular Risk: Lipid Ratios as Risk Factors for Cardiovascular Disease
Pereira, T. S. (2012) · InTech eBooks · doi:10.5772/27378 · Cited by 18
TaqIB polymorphism in the cholesteryl ester transfer protein (CETP) gene influences lipid responses to the consumption of kiwifruit in hypercholesterolaemic men
Gammon, C. S., Minihane, A. M., Kruger, R., Conlon, C. A., von Hurst, P. R., Jones, B., & Stonehouse, W. (2013) · British Journal Of Nutrition · doi:10.1017/s0007114513003437 · Cited by 18
Functional Promoter Variant in Zinc Finger Protein 202 Predicts Severe Atherosclerosis and Ischemic Heart Disease
Stene, M. C. A., Frikke‐Schmidt, R., Nordestgaard, B. G., Grande, P., Schnohr, P., & Tybjærg‐Hansen, A. (2008) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2008.03.059 · Cited by 18
Effects of Cyclosporine-Tacrolimus Switching in Posttransplantation Hyperlipidemia on High-Density Lipoprotein 2/3, Lipoprotein A1/B, and Other Lipid Parameters
Seymen, P., Yildiz, M., Türkmen, M., Titiz, M. İ., & Seymen, H. O. (2009) · Transplantation Proceedings · doi:10.1016/j.transproceed.2009.09.069 · Cited by 18
Atherogenic Lipid Profile in Behçet’s Disease: Evidence of Alteration of HDL Subclasses
Messedi, M., Jamoussi, K., Frigui, M., Laporte, F., Turki, M., Chaabouni, K., Mnif, E., Jallouli, M., Kaddour, N., Bahloul, Z., et al. (2011) · Archives of Medical Research · doi:10.1016/j.arcmed.2011.05.001 · Cited by 18
Rapeseed oil and rapeseed oil-based margarine for the prevention and treatment of coronary heart disease
de Lorgeril, M., Salen, P., Laporte, F., Foulon, T., Payen, N., & de Leiris, J. (2001) · European Journal of Lipid Science and Technology · doi:10.1002/1438-9312(200107)103:7 · Cited by 11
Vino y corazón
Llerena, I. R., & Huerta, E. M. (1998) · Revista Española de Cardiología · doi:10.1016/s0300-8932(98)74772-4 · Cited by 18
The effect on transcription efficiency of the apolipoprotein AI gene of DNA variants at the 5′ untranslated region
Wang, X. L., Badenhop, R. B., Sim, A. S., & Wilcken, D. E. L. (1998) · International Journal of Clinical & Laboratory Research · doi:10.1007/s005990050051 · Cited by 18
Alcohol drinking and cardiac risk
Buemann, B., Dyerberg, J., & Astrup, A. V. (2002) · Nutrition Research Reviews · doi:10.1079/nrr200235 · Cited by 18
A nine-month, placebo-controlled study of the effects of growth hormone treatment on lipoproteins and LDL size in abdominally obese men
Svensson, J., Bengtsson, B. ‐., Taskinen, M., Wiklund, O., & Johannsson, G. (2000) · Growth Hormone & IGF Research · doi:10.1054/ghir.2000.0148 · Cited by 18
Assessment of Different Atherogenic Indices as Predictors of Metabolic Syndrome in Spanish Adolescents
Fernández‐Aparicio, Á., Perona, J. S., Schmidt‐RioValle, J., Padez, C. M. P., & González‐Jiménez, E. (2021) · Biological Research For Nursing · doi:10.1177/10998004211050887 · Cited by 17
See the Seal? Understanding Restrained Eaters’ Responses to Nutritional Messages on Food Packaging
Lwin, M. O., Morrin, M., Tang, S. W. H., Low, J. Y., Nguyen, T., & Lee, W. X. (2013) · Health Communication · doi:10.1080/10410236.2013.789131 · Cited by 17
Analysis of Lipoproteins and Body Mass Index in Professional Football Players
Garry, J. P., & McShane, J. J. (2001) · Preventive Cardiology · doi:10.1111/j.1520-037x.2001.00534.x · Cited by 18
Introduction: Apolipoproteins and guidelines for prevention of cardiovascular disease
Færgeman, O. (2006) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2006.01650.x · Cited by 18
Potential role of the interaction between equine estrogens, low-density lipoprotein (LDL) and high-density lipoprotein (HDL) in the prevention of coronary heart and neurodegenerative diseases in postmenopausal women.
Perrella, J., Berco, M., Cecutti, A., Gerulath, A. H., & Bhavnani, B. R. (2003) · Lipids in Health and Disease · doi:10.1186/1476-511x-2-4 · Cited by 17
Plasmin and Kallikrein Reduce HDL-Induced Cholesterol Efflux from Foam Cells
Lindstedt, L., & Kovanen, P. T. (2000) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2000.3704 · Cited by 17
“Is there a safe level of alcohol consumption for men and women?” Some progress
Pols, R. G., & Hawks, D. (1992) · Drug and Alcohol Review · doi:10.1080/09595239200185461 · Cited by 18
Subcutaneous calcifications in a patient with diffuse scleroderma.
Park, Y.-J., Yoo, S.-A., Lee, J., Chung, Y.-J., Cho, C., & Kim, W. (2013) · PubMed · Cited by 16
Investigating the effects of negative-calorie diet compared with low-calorie diet under exercise conditions on weight loss and lipid profile in overweight/obese middle-aged and older men
Rezaeipour, M., Apanasenko, G. L., & Nychyporuk, V. I. (2014) · TURKISH JOURNAL OF MEDICAL SCIENCES · doi:10.3906/sag-1303-10 · Cited by 16
Association between chemokine receptor 5 (CCR5) delta32 gene variant and atherosclerosis: a meta-analysis of 13 studies.
Zhang, Z., Liu, J., Wang, H., Wu, H., Wu, X., Dong, J., & Liao, L. (2015) · PubMed Central · Cited by 16
Should apolipoprotein B replace LDL cholesterol as therapeutic targets are lowered?
Meeusen, J. W., Donato, L. J., & Jaffe, A. S. (2016) · Current Opinion in Lipidology · doi:10.1097/mol.0000000000000313 · Cited by 17
Secretion of preβ HDL increases with the suppression of cholesteryl ester transfer protein in Hep G2 cells
Sawada, S., Sugano, M., Makino, N., Okamoto, H., & Tsuchida, K. (1999) · Atherosclerosis · doi:10.1016/s0021-9150(99)00152-5 · Cited by 16
Reduction of Lipid Hydroperoxides by Apolipoprotein B-100
Mashima, R., Yoshimura, S., & Yamamoto, Y. (1999) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1999.0739 · Cited by 16
Trans Fatty Acids Affect Lipoprotein Metabolism in Rats
Gatto, L. M., Lyons, M. A., Brown, A. J., & Samman, S. (2002) · Journal of Nutrition · doi:10.1093/jn/132.6.1242 · Cited by 16
Comparison of two methods (precipitation manual and fully automated enzymatic) for the analysis of HDL and LDL cholesterol.
Jabbar, J., Siddiqui, I., & Raza, Q. (2006) · PubMed · Cited by 16
Loss of abdominal fat and improvement of the cardiovascular risk profile by regular moderate exercise training in patients with NIDDM
Lehmann, R., Vokac, A., Niedermann, K., Agosti, K., & Spinas, G. A. (1995) · Diabetologia · doi:10.1007/s001250050429 · Cited by 16
Do No Harm
Weinberger, M. H. (1992) · Archives of Internal Medicine · doi:10.1001/archinte.1992.00400150007001 · Cited by 16
Plasma cholesterol and other cardiac risk factors in adolescent girls.
Bermingham, M., Jones, E., Steinbeck, K. S., & Brock, K. E. (1995) · Archives of Disease in Childhood · doi:10.1136/adc.73.5.392 · Cited by 16
Relationship of dietary intake to hospital admission for coronary heart and vascular disease: the NHANES II national probability study.
Gartside, P. S., & Glueck, C. J. (1993) · Journal of the American College of Nutrition · doi:10.1080/07315724.1993.10718359 · Cited by 16
Cyclosporin A Trough Levels Correlate With Serum Lipoproteins and Apolipoproteins
von Ahsen, N., Helmhold, M., Schütz, E., Eisenhauer, T., Armstrong, V. W., & Oellerich, M. (1997) · Therapeutic Drug Monitoring · doi:10.1097/00007691-199704000-00004 · Cited by 16
Management of hyperlipidaemia
BMJ Publishing Group Ltd (1996) · Drug and Therapeutics Bulletin · doi:10.1136/dtb.1996.341289 · Cited by 16
Lipid Abnormalities in Chronic Uremic Patients
Elisaf, M., Dardamanis, M. A., Papagalanis, N. D., & Siamopoulos, K. C. (1993) · Scandinavian Journal of Urology and Nephrology · doi:10.3109/00365599309180423 · Cited by 16
G-protein-coupled estrogen receptor as a new therapeutic target for treating coronary artery disease
Han, G. (2014) · World Journal of Cardiology · doi:10.4330/wjc.v6.i6.367 · Cited by 15
Health burden of unbalanced fatty acids intake from 1990 to 2019: A global analysis
Hu, J., Dong, Y., Ding, R., Yang, J.-C., Odkhuu, E., Zhang, L., & Ye, D.-W. (2023) · Med · doi:10.1016/j.medj.2023.08.002 · Cited by 15
Lipid-lowering effects of Coriolus versicolor extract in poloxamer 407-induced hypercholesterolaemic rats and high cholesterol-fed rats
Hor, S. Y., Farsi, E., Yam, M. F., Nuyah, N. M., & Asmawi, M. Z. (2011) · Journal of Medicinal Plants Research · doi:10.5897/jmpr.9000853 · Cited by 15
Lipoprotein Ratios as Surrogate Markers for Insulin Resistance in South Indians with Normoglycemic Nondiabetic Acute Coronary Syndrome
Rajappa, M., Sridhar, M. G., Balachander, J., Sethuraman, K. R., & Rajendiran, K. S. (2014) · ISRN Endocrinology · doi:10.1155/2014/981524 · Cited by 15
Effect of physical exercise on lipid metabolism in the elderly.
Veríssimo, M. T., Aragão, A., Sousa, A. C., Barbosa, B., Ribeiro, H., Costa, D., & Saldanha, M. H. (2002) · PubMed · Cited by 15
An elevation of triglycerides reflecting decreased triglyceride clearance may not be pathogenic – relevance to high-carbohydrate diets
McCarty, M. F. (2004) · Medical Hypotheses · doi:10.1016/j.mehy.2002.11.002 · Cited by 15
Refusing to treat smokers is unethical and a dangerous precedent.
Shiu, M. (1993) · BMJ · doi:10.1136/bmj.306.6884.1048 · Cited by 15
Oxidised LDL (OxLDL) induces production of platelet derived growth factor AA (PDGF AA) from aortic smooth muscle cells
Cucina, A., Pagliei, S., Borrelli, V., Corvino, V., Stipa, F., Cavallaro, A., & Sterpetti, A. V. (1998) · European Journal of Vascular and Endovascular Surgery · doi:10.1016/s1078-5884(98)80220-7 · Cited by 15
Lack of association between plasma lipoprotein(a) concentrations and the presence or absence of coronary atherosclerosis
Auer, J., Rammer, M., Berent, R., Weber, T., Laßnig, E., & Eber, B. (2002) · Acta Cardiologica · doi:10.2143/ac.57.6.2005464 · Cited by 15
ARE HIGHER ALCOHOL TAXES JUSTIFIED
Heien, D. (1995) · RePEc: Research Papers in Economics · Cited by 15
Fibrinolytic Factors, Serum Lipid and C-reactive Protein Predicting Cardiac Events in Japanese Patients With Coronary Atherosclerotic Lesions
Soeki, T., Tamura, Y., Shinohara, H., Tanaka, H., Bando, K., Yui, Y., & Fukuda, N. (1999) · Japanese Circulation Journal-english Edition · doi:10.1253/jcj.63.976 · Cited by 15
Immediate Metabolic Response Following Sleeve Gastrectomy in Obese Diabetics
Meydan, C., Goldstein, N., Weiss-Shwartz, E., Lederfine, D., Goitein, D., Rubin, M., & Spivak, H. (2015) · Obesity Surgery · doi:10.1007/s11695-015-1669-8 · Cited by 14
Post-transcriptional nature of uremia-induced downregulation of hepatic apolipoprotein A-I production
Moradi, H., Said, H. M., & Vaziri, N. D. (2012) · Translational research · doi:10.1016/j.trsl.2012.11.001 · Cited by 14
Efficacy and safety of statins in hypercholesterolemia with emphasis on lipoproteins
Wu, S.-C., Shiang, J.-C., Lin, S.-L., Wu, T.-L., Huang, W.-C., Chiou, K.-R., & Liu, C.-P. (2005) · Heart and Vessels · doi:10.1007/s00380-005-0836-6 · Cited by 14
High-density lipoprotein associations with coronary heart disease: Does measurement of cholesterol content give the best result?
Cromwell, W. C. (2007) · Journal of clinical lipidology · doi:10.1016/j.jacl.2007.01.002 · Cited by 14
Association of low-density lipoprotein particle size and ratio of different lipoproteins and apolipoproteins with coronary heart disease
Biswas, S., Ghoshal, P. K., Mandal, S. C., & Mandal, N. (2008) · Journal of Cardiology · doi:10.1016/j.jjcc.2008.06.005 · Cited by 14
Analyzing of high-density lipoprotein subfractions and low-density lipoprotein subfractions in human serum with anion-exchange chromatography
Hirowatari, Y., Tsunoda, Y., Ogura, Y., & Homma, Y. (2008) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2008.10.031 · Cited by 14
Change in High-Density Lipoprotein Cholesterol and Incident Coronary Heart Disease in Apparently Healthy Male Physicians
Rahilly‐Tierney, C. R., Bowman, T. S., Djoussé, L., Sesso, H. D., & Gaziano, J. M. (2008) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2008.07.055 · Cited by 14
Impact on cardiovascular events of increasing high density lipoprotein cholesterol with and without lipid lowering drugs
Li, W., Murphy, M. J., & MacDonald, T. M. (2005) · Heart · doi:10.1136/hrt.2005.068411 · Cited by 14

Authors: Stampfer, M. J., Sacks, F. M., Salvini, S., Willett, W. C., & Hennekens, C. H.
Affiliations: Brigham and Women's Hospital (US)
ORCID: Stampfer, Meir J.
Sacks, Frank M.
Willett, Walter C.
Hennekens, Charles H.
Venue: New England Journal of Medicine
Publisher: Massachusetts Medical Society
Published: 1991-08-08
Volume: 325
Issue: 6
Pages: 373-381
ISSN: 0028-4793 (ISSN-L)
1533-4406
DOI: 10.1056/nejm199108083250601
OpenAlex: W2337032743
Cited by: 1,163
References: 56
Citations by year: 2026: 6 · 2025: 5 · 2024: 10 · 2023: 10 · 2022: 7 · 2021: 12 · 2020: 14 · 2019: 12 · 2018: 18 · 2017: 17 · 2016: 24 · 2015: 31 · 2014: 34 · 2013: 33 · 2012: 31
FWCI: 80.75
Type: journal article
Language: en
Open access: bronze
doi.org
Locations: New England Journal of Medicine (publishedVersion)
PubMed (publishedVersion)
Funders: National Heart, Lung, and Blood Institute (HL-34595, HL 26490, R01HL034595)
National Cancer Institute (R01CA042182, CA 42182)
Topics: Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipoproteins and Cardiovascular Health
Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Cholesterol and Lipid Metabolism
Life Sciences › Biochemistry, Genetics and Molecular Biology › Clinical Biochemistry › Paraoxonase enzyme and polymorphisms
Keywords: myocardial infarction, HDL cholesterol, HDL2, HDL3, apolipoprotein B-100, apolipoprotein A-I, apolipoprotein A-II, TC/HDL-C ratio, cardiovascular risk prediction, total cholesterol, men, Physicians' Health Study, lipoprotein subfractions, risk factors, coronary heart disease prevention, statin therapy
MeSH terms: Adult, Aged, Aged, 80 and over, Apolipoproteins, Apolipoproteins A, Apolipoproteins B, Cholesterol, Humans, Cholesterol, HDL, Male, Middle Aged, Myocardial Infarction, Prospective Studies, Risk Factors

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

A prospective study of cholesterol, apolipoproteins, and the risk of myocardial infarction.

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks